Latest Articles

Publication Date
The molecular role of RE1 silencing transcription factor in uterine diseases: is there potential for targeted therapeutic development?

Published: Sept. 3, 2025, midnight
The prevalence of endometriosis in adult female patients with hidradenitis suppurativa: a cross-sectional study using the All of Us Research Program.

Published: Sept. 3, 2025, midnight
Improving the reporting on health equity in observational research (STROBE-Equity): extension checklist and elaboration.

Published: Sept. 3, 2025, midnight
Machine learning prediction of clinical pregnancy in endometriosis patients following fresh IVF/ICSI-ET.

Fresh embryo transfer reduces waiting time and minimizes embryo cryodamage for endometriosis (EM) patients. The current prediction models for fresh embryo transfer outcomes in EM primarily rely on logistic regression, …

Published: Sept. 3, 2025, midnight
Initial results in the automatic visual recognition of endometriosis lesions by artificial intelligence during laparoscopy: a proof-of-concept study.

To develop a machine learning method for the automatic recognition of endometriosis lesions during laparoscopic surgery and evaluate its feasibility and performance.

Published: Sept. 3, 2025, midnight
The Impact of Lifestyle on Reproductive Health: Microbial Complexity, Hormonal Dysfunction, and Pregnancy Outcomes.

Endocrine dysfunctions refer to alterations in hormone production, release, or regulation that can significantly impact health. In pregnant women or those planning pregnancy, these conditions may manifest as disorders such …

Published: Sept. 3, 2025, midnight
Molecule Shows Promise for MASH, Endometriosis, and Other Chronic Diseases | Newswise - Newswise

Molecule Shows Promise for MASH, Endometriosis, and Other Chronic Diseases | Newswise Newswise

Published: Sept. 2, 2025, 11:05 p.m.
Molecule Shows Promise for MASH, Endometriosis, and Other Chronic Diseases - Yale School of Medicine

Molecule Shows Promise for MASH, Endometriosis, and Other Chronic Diseases Yale School of Medicine

Published: Sept. 2, 2025, 12:57 p.m.
Leuprolide Acetate Market to Reach USD 4.43 Billion by 2032 as Demand for Hormone Therapy Accelerates – SNS Insider - SINA HONG KONG LIMITED

Leuprolide Acetate Market to Reach USD 4.43 Billion by 2032 as Demand for Hormone Therapy Accelerates – SNS Insider SINA HONG KONG LIMITED

Published: Sept. 2, 2025, 11:40 a.m.
Leuprolide Acetate Market to Reach USD 4.43 Billion by 2032 - GlobeNewswire

Leuprolide Acetate Market to Reach USD 4.43 Billion by 2032 GlobeNewswire

Published: Sept. 2, 2025, 10:32 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!